Landry S, Mettu R, Kolls J, Aberle J, Norton E, Zwezdaryk K
Biochemistry. 2023; 62(17):2517-2529.
PMID: 37554055
PMC: 10483696.
DOI: 10.1021/acs.biochem.3c00335.
Sadegh-Nasseri S
Crit Rev Immunol. 2021; 40(5):449-464.
PMID: 33463956
PMC: 11014643.
DOI: 10.1615/CritRevImmunol.2020035324.
Reyes-Vargas E, Barker A, Zhou Z, He X, Jensen P
J Biol Chem. 2020; 295(10):2959-2973.
PMID: 31969393
PMC: 7062162.
DOI: 10.1074/jbc.RA119.010645.
Nanaware P, Jurewicz M, Leszyk J, Shaffer S, Stern L
Mol Cell Proteomics. 2018; 18(3):490-503.
PMID: 30573663
PMC: 6398211.
DOI: 10.1074/mcp.RA118.000956.
Jurewicz M, Stern L
Immunogenetics. 2018; 71(3):171-187.
PMID: 30421030
PMC: 6377339.
DOI: 10.1007/s00251-018-1095-x.
A step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cells.
Sadegh-Nasseri S
F1000Res. 2016; 5.
PMID: 27347387
PMC: 4902097.
DOI: 10.12688/f1000research.7664.1.
Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.
Falconer J, Mahida R, Venkatesh D, Pearson J, Robinson J
Immunology. 2015; 147(4):389-98.
PMID: 26581676
PMC: 4799888.
DOI: 10.1111/imm.12557.
Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.
Yin L, Trenh P, Guce A, Wieczorek M, Lange S, Sticht J
J Biol Chem. 2014; 289(34):23449-64.
PMID: 25002586
PMC: 4156084.
DOI: 10.1074/jbc.M114.585539.
Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.
God J, Zhao D, Cameron C, Amria S, Bethard J, Haque A
Immunology. 2014; 142(3):492-505.
PMID: 24628049
PMC: 4080965.
DOI: 10.1111/imm.12281.
A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.
Yin L, Stern L
J Immunol Methods. 2014; 406:21-33.
PMID: 24583195
PMC: 4029850.
DOI: 10.1016/j.jim.2014.02.008.
Mechanisms of peptide repertoire selection by HLA-DM.
Pos W, Sethi D, Wucherpfennig K
Trends Immunol. 2013; 34(10):495-501.
PMID: 23835076
PMC: 3796002.
DOI: 10.1016/j.it.2013.06.002.
Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.
Pos W, Sethi D, Call M, Schulze M, Anders A, Pyrdol J
Cell. 2012; 151(7):1557-68.
PMID: 23260142
PMC: 3530167.
DOI: 10.1016/j.cell.2012.11.025.
HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.
Yin L, Calvo-Calle J, Dominguez-Amorocho O, Stern L
J Immunol. 2012; 189(8):3983-94.
PMID: 22966084
PMC: 3466378.
DOI: 10.4049/jimmunol.1200626.
The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze M, Wucherpfennig K
Curr Opin Immunol. 2011; 24(1):105-11.
PMID: 22138314
PMC: 3288754.
DOI: 10.1016/j.coi.2011.11.004.
Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.
Painter C, Negroni M, Kellersberger K, Zavala-Ruiz Z, Evans J, Stern L
Proc Natl Acad Sci U S A. 2011; 108(48):19329-34.
PMID: 22084083
PMC: 3228433.
DOI: 10.1073/pnas.1108074108.
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide.
Anders A, Call M, Schulze M, Fowler K, Schubert D, Seth N
Nat Immunol. 2010; 12(1):54-61.
PMID: 21131964
PMC: 3018327.
DOI: 10.1038/ni.1967.
Understanding the focused CD4 T cell response to antigen and pathogenic organisms.
Weaver J, Sant A
Immunol Res. 2009; 45(2-3):123-43.
PMID: 19198764
DOI: 10.1007/s12026-009-8095-8.
Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.
Weaver J, Lazarski C, Richards K, Chaves F, Jenks S, Menges P
J Immunol. 2008; 181(5):3039-48.
PMID: 18713974
PMC: 2814425.
DOI: 10.4049/jimmunol.181.5.3039.
An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.
Menges P, Jenks S, Bikoff E, Friedmann D, Knowlden Z, Sant A
J Immunol. 2008; 180(3):1619-33.
PMID: 18209058
PMC: 2981066.
DOI: 10.4049/jimmunol.180.3.1619.
Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.
Grotenbreg G, Nicholson M, Fowler K, Wilbuer K, Octavio L, Yang M
J Biol Chem. 2007; 282(29):21425-36.
PMID: 17525157
PMC: 3427782.
DOI: 10.1074/jbc.M702844200.